Form D Filing: Exagen Diagnostics $995889 Fundraising. Wendy Swedick Released Nov 10 Filing

Biotechnology Exagen Diagnostics Inc - Wendy Swedick

Exagen Diagnostics Financing

Exagen Diagnostics Inc, Corporation just submitted form D announcing $995,889 debt financing. This is a new filing. Exagen Diagnostics was able to fundraise $995,889. That is 100.00% of the round of financing. The total financing amount was $995,889. This form was filed on 2016-11-10. The reason for the financing was: unspecified.

Exagen Diagnostics is based in California. The filler’s business is Biotechnology. The SEC form was signed by Wendy Swedick Chief Financial Officer. The company was incorporated more than five years ago. The filler’s address is: 1261 Liberty Way, Vista, Ca, California, 92081. Fortunato R. Rocca is the related person in the form and it has address: 1261 Liberty Way, Vista, Ca, California, 92081. Link to Exagen Diagnostics Filing: 000114036116085750.

Analysis of Exagen Diagnostics Offering

On average, startups in the Biotechnology sector, sell 73.77% of the total offering size. Exagen Diagnostics sold 100.00% of the offering. Could this mean that the trust in Exagen Diagnostics is high? The average investment floor size for companies in the Biotechnology industry is $3.08 million. The offering was 67.67% smaller than the average of $3.08 million. Of course this should not be taken as negative. Businesses raise funds for different needs and reasons. The minimum investment for this financing was set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Exagen Diagnostics Also

The Form D signed by Wendy Swedick might help Exagen Diagnostics Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment